BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11029468)

  • 1. Kinetic basis for activation of CDK2/cyclin A by phosphorylation.
    Hagopian JC; Kirtley MP; Stevenson LM; Gergis RM; Russo AA; Pavletich NP; Parsons SM; Lew J
    J Biol Chem; 2001 Jan; 276(1):275-80. PubMed ID: 11029468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of activation of ERK2 by dual phosphorylation.
    Prowse CN; Lew J
    J Biol Chem; 2001 Jan; 276(1):99-103. PubMed ID: 11016942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation mechanism of CDK2: role of cyclin binding versus phosphorylation.
    Stevenson LM; Deal MS; Hagopian JC; Lew J
    Biochemistry; 2002 Jul; 41(26):8528-34. PubMed ID: 12081504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complete pathway for catalytic activation of the mitogen-activated protein kinase, ERK2.
    Prowse CN; Deal MS; Lew J
    J Biol Chem; 2001 Nov; 276(44):40817-23. PubMed ID: 11524422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies on phospho-CDK2/cyclin A bound to nitrate, a transition state analogue: implications for the protein kinase mechanism.
    Cook A; Lowe ED; Chrysina ED; Skamnaki VT; Oikonomakos NG; Johnson LN
    Biochemistry; 2002 Jun; 41(23):7301-11. PubMed ID: 12044161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
    Brown NR; Noble ME; Endicott JA; Johnson LN
    Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
    Brown NR; Noble ME; Lawrie AM; Morris MC; Tunnah P; Divita G; Johnson LN; Endicott JA
    J Biol Chem; 1999 Mar; 274(13):8746-56. PubMed ID: 10085115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine.
    Kaldis P; Cheng A; Solomon MJ
    J Biol Chem; 2000 Oct; 275(42):32578-84. PubMed ID: 10931829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk.
    Morris MC; Gondeau C; Tainer JA; Divita G
    J Biol Chem; 2002 Jun; 277(26):23847-53. PubMed ID: 11959850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of cyclin-dependent kinase activation by phosphorylation.
    Russo AA; Jeffrey PD; Pavletich NP
    Nat Struct Biol; 1996 Aug; 3(8):696-700. PubMed ID: 8756328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
    Jeffrey PD; Russo AA; Polyak K; Gibbs E; Hurwitz J; Massagué J; Pavletich NP
    Nature; 1995 Jul; 376(6538):313-20. PubMed ID: 7630397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2.
    Yam CH; Siu WY; Lau A; Poon RY
    J Biol Chem; 2000 Feb; 275(5):3158-67. PubMed ID: 10652300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of mammalian cyclin-dependent kinase 2.
    Sheaff RJ
    Methods Enzymol; 1997; 283():173-93. PubMed ID: 9251019
    [No Abstract]   [Full Text] [Related]  

  • 15. The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism.
    Clare PM; Poorman RA; Kelley LC; Watenpaugh KD; Bannow CA; Leach KL
    J Biol Chem; 2001 Dec; 276(51):48292-9. PubMed ID: 11604388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
    Lents NH; Keenan SM; Bellone C; Baldassare JJ
    J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.
    Schulman BA; Lindstrom DL; Harlow E
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10453-8. PubMed ID: 9724724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of phosphorylated cyclin-dependent kinase 2 and functional characterization of threonine-160-specific phosphatase KAP.
    Poon RY
    Methods Enzymol; 1997; 283():283-92. PubMed ID: 9251027
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclin-stimulated binding of Cks proteins to cyclin-dependent kinases.
    Egan EA; Solomon MJ
    Mol Cell Biol; 1998 Jul; 18(7):3659-67. PubMed ID: 9632748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.